H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

Zongkuo Li; Menglong Hu; Jinhuan Qiu; Junkai Feng; Ruizhen Zhang; Huifang Wu; Guiming Hu; Jingli Ren

doi:10.12659/MSM.933447

14 January 2022 : Database Analysis

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

Zongkuo Li^12AE, Menglong Hu^12A, Jinhuan Qiu^12C, Junkai Feng^12C, Ruizhen Zhang^1C, Huifang Wu^1D, Guiming Hu^1D, Jingli Ren^1G*

DOI: 10.12659/MSM.933447

Med Sci Monit 2022; 28:e933447

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 8 Correlation of H2AFZ with TIICs in LUAD. (A) Proportions of the 22 tumor-infiltrating immune cell subtypes in high and low H2AFZ expression groups. (B) Correlation between H2AFZ expression and immune cells in LUAD. (C) The combined impact of H2AFZ expression and MDSC infiltration on the survival of LUAD patients. R 4.1.0 software (R Development Core Team, Vienna).

Back to the Article

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

Your Privacy